MED GEN INC
10KSB, EX-27, 2000-12-22
PHARMACEUTICAL PREPARATIONS
Previous: MED GEN INC, 10KSB, 2000-12-22
Next: PNV INC, 8-K, 2000-12-22



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This Summary Financial Data Schedule contains summary financial information
extracted from Balance Sheet,  Statement of Cash Flows, Statement of Operations
and Notes thereto incorporated in Part I, Item 1 of this Form 10-KSB and is
qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                              27
<SECURITIES>                                         0
<RECEIVABLES>                                  260,349
<ALLOWANCES>                                   139,687
<INVENTORY>                                     66,551
<CURRENT-ASSETS>                               466,614
<PP&E>                                         145,211
<DEPRECIATION>                                (12,837)
<TOTAL-ASSETS>                                 589,988
<CURRENT-LIABILITIES>                          429,173
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         4,445
<OTHER-SE>                                     169,815
<TOTAL-LIABILITY-AND-EQUITY>                   598,988
<SALES>                                      1,519,336
<TOTAL-REVENUES>                             1,519,336
<CGS>                                          437,258
<TOTAL-COSTS>                                  437,258
<OTHER-EXPENSES>                             1,259,608
<LOSS-PROVISION>                                 3,785
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (181,315)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (181,315)
<EPS-BASIC>                                     (0.05)
<EPS-DILUTED>                                   (0.05)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission